Alector Inc (NASDAQ:ALEC) Director Orbimed Advisors Llc purchased 411,700 shares of the firm’s stock in a transaction on Monday, February 11th. The shares were acquired at an average cost of $19.00 per share, for a total transaction of $7,822,300.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of Alector stock opened at $18.25 on Thursday.
COPYRIGHT VIOLATION WARNING: “Alector Inc (ALEC) Director Orbimed Advisors Llc Acquires 411,700 Shares” was originally posted by Week Herald and is the property of of Week Herald. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://weekherald.com/2019/02/14/alector-inc-alec-director-orbimed-advisors-llc-acquires-411700-shares.html.
Alector, Inc, a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease.
Further Reading: How Do Investors Open a Backdoor Roth IRA?
Receive News & Ratings for Alector Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alector and related companies with MarketBeat.com's FREE daily email newsletter.